Aspirin therapy for cancer: it is never too late

被引：2
作者：
Jankowski, J. A. Z. [1 ]
Limburg, P. J. [2 ]
机构：
[1] Dept Oncol, Oxford OX3 7DQ, England
[2] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA
来源：
BRITISH JOURNAL OF CANCER | 2011年 / 105卷 / 08期
关键词：
COLORECTAL-CANCER; PREVENTION; SURVIVAL;
D O I：
10.1038/bjc.2011.373
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1105 / 1106
页数：2
相关论文
共 12 条
  • [1] Aspirin Use and Survival After Diagnosis of Colorectal Cancer
    Chan, Andrew T.
    Ogino, Shuji
    Fuchs, Charles S.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (06): : 649 - 659
  • [2] Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
    Cuzick, Jack
    Otto, Florian
    Baron, John A.
    Brown, Powel H.
    Burn, John
    Greenwald, Peter
    Jankowski, Janusz
    La Vecchia, Carlo
    Meyskens, Frank
    Senn, Hans Joerg
    Thun, Michael
    [J]. LANCET ONCOLOGY, 2009, 10 (05) : 501 - 507
  • [3] COX-2 as a target for cancer chemotherapy
    Ghosh, Nilanjan
    Chaki, Rituparna
    Mandal, Vivekananda
    Mandal, Subhash C.
    [J]. PHARMACOLOGICAL REPORTS, 2010, 62 (02) : 233 - 244
  • [4] Aspirin Intake and Survival After Breast Cancer
    Holmes, Michelle D.
    Chen, Wendy Y.
    Li, Lisa
    Hertzmark, Ellen
    Spiegelman, Donna
    Hankinson, Susan E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (09) : 1467 - 1472
  • [5] A methodologic analysis of chemoprevention and cancer prevention strategies for gastrointestinal cancer
    Jankowski, JA
    Hawk, ET
    [J]. NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2006, 3 (02): : 101 - 111
  • [6] Cyclooxygenase-2 inhibitors in colorectal cancer prevention: Counterpoint
    Jankowski, Janusz
    Hunt, Richard
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (08) : 1858 - 1861
  • [7] Colorectal cancer risk, chronic illnesses, operations and medications: case-control results from the Melbourne Colorectal Cancer Study (Reprinted from Cancer Research, vol 48, pg 4399-404, 1988)
    Kune, Gabriel A.
    Kune, Susan
    Watson, Lyndsey F.
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2007, 36 (05) : 951 - 957
  • [8] Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?
    Langley, R. E.
    Burdett, S.
    Tierney, J. F.
    Cafferty, F.
    Parmar, M. K. B.
    Venning, G.
    [J]. BRITISH JOURNAL OF CANCER, 2011, 105 (08) : 1107 - 1113
  • [9] The historical analysis of aspirin discovery, its relation to the willow tree and antiproliferative and anticancer potential
    Mahdi, JG
    Mahdi, AJ
    Mahdi, AJ
    Bowen, ID
    [J]. CELL PROLIFERATION, 2006, 39 (02) : 147 - 155
  • [10] Phase III Randomized Trial Assessing Rofecoxib in the Adjuvant Setting of Colorectal Cancer: Final Results of the VICTOR Trial
    Midgley, Rachel S.
    McConkey, Christopher C.
    Johnstone, Elaine C.
    Dunn, Janet A.
    Smith, Justine L.
    Grumett, Simon A.
    Julier, Patrick
    Iveson, Claire
    Yanagisawa, Yoko
    Warren, Bryan
    Langman, Michael J.
    Kerr, David J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (30) : 4575 - 4580
12